scispace - formally typeset
Open AccessJournal ArticleDOI

Systemic Delivery of Synthetic MicroRNA-16 Inhibits the Growth of Metastatic Prostate Tumors via Downregulation of Multiple Cell-cycle Genes

Reads0
Chats0
TLDR
The therapeutic potential of miRNA in an animal model of cancer metastasis with systemic miRNA injection is indicated and systemic delivery of miR-16 could be used to treat patients with advanced prostate cancer.
About:Ā 
This article is published in Molecular Therapy.The article was published on 2010-01-01 and is currently open access. It has received 419 citations till now. The article focuses on the topics: PCA3 & DU145.

read more

Citations
More filters
Journal ArticleDOI

Secretory Mechanisms and Intercellular Transfer of MicroRNAs in Living Cells

TL;DR: It is shown that miRNAs are released through a ceramide-dependent secretory machinery and that the secretory miRNAAs are transferable and functional in the recipient cells and that a tumor-suppressive miRNA secreted via this pathway was transported between cells and exerted gene silencing in the recipients cells, thereby leading to cell growth inhibition.
Journal ArticleDOI

Tumor angiogenesis: molecular pathways and therapeutic targets

TL;DR: A durable and efficient antiangiogenic response will require approaches to simultaneously or sequentially target multiple aspects of the tumor microenvironment.
Journal ArticleDOI

microRNAs in cancer management.

TL;DR: This Review summarises the present understanding of how miRNAs operate at the molecular level; how their dysregulation is a crucial part of tumour formation, maintenance, and metastasis; how they can be used as biomarkers for disease type and grade; and how miRNA-based treatments could be used for diverse types of malignancies.
Journal ArticleDOI

siRNA Versus miRNA as Therapeutics for Gene Silencing

TL;DR: This review provides a comparison between therapeutic siRNAs and miRNAs in terms of their mechanisms of action, physicochemical properties, delivery, and clinical applications and the challenges in developing both classes of RNA as therapeutics.
Journal ArticleDOI

Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34

TL;DR: The development of a therapeutic formulation using chemically synthesized miR-34a and a lipid-based delivery vehicle that blocks tumor growth in mouse models of non-small-cell lung cancer is described, providing proof of concept for the systemic delivery of a synthetic tumor suppressor mimic.
References
More filters
Journal ArticleDOI

KEGG: Kyoto Encyclopedia of Genes and Genomes

TL;DR: The Kyoto Encyclopedia of Genes and Genomes (KEGG) as discussed by the authors is a knowledge base for systematic analysis of gene functions in terms of the networks of genes and molecules.
Journal ArticleDOI

Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets

TL;DR: In a four-genome analysis of 3' UTRs, approximately 13,000 regulatory relationships were detected above the estimate of false-positive predictions, thereby implicating as miRNA targets more than 5300 human genes, which represented 30% of the gene set.
Journal ArticleDOI

MicroRNA expression profiles classify human cancers

TL;DR: A new, bead-based flow cytometric miRNA expression profiling method is used to present a systematic expression analysis of 217 mammalian miRNAs from 334 samples, including multiple human cancers, and finds the miRNA profiles are surprisingly informative, reflecting the developmental lineage and differentiation state of the tumours.
Journal ArticleDOI

DAVID: Database for Annotation, Visualization, and Integrated Discovery

TL;DR: DAMID is a web-accessible program that integrates functional genomic annotations with intuitive graphical summaries that assists in the interpretation of genome-scale datasets by facilitating the transition from data collection to biological meaning.
Related Papers (5)